Skip to main content

Peer Review reports

From: Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience

Original Submission
1 Mar 2018 Submitted Original manuscript
27 Mar 2018 Reviewed Reviewer Report - Anthony D. Elias
6 Apr 2018 Reviewed Reviewer Report - Alessandro Sindoni
16 Apr 2018 Reviewed Reviewer Report - Alexander Siebenhuener
23 Apr 2018 Author responded Author comments - Danielle Glassman
Resubmission - Version 2
23 Apr 2018 Submitted Manuscript version 2
24 Apr 2018 Reviewed Reviewer Report - Alessandro Sindoni
24 Apr 2018 Reviewed Reviewer Report - Anthony D. Elias
26 Apr 2018 Author responded Author comments - Danielle Glassman
Resubmission - Version 3
26 Apr 2018 Submitted Manuscript version 3
11 May 2018 Reviewed Reviewer Report - Atsushi Takano
28 May 2018 Author responded Author comments - Danielle Glassman
Resubmission - Version 4
28 May 2018 Submitted Manuscript version 4
11 Jun 2018 Author responded Author comments - Danielle Glassman
Resubmission - Version 5
11 Jun 2018 Submitted Manuscript version 5
Publishing
18 Jun 2018 Editorially accepted
27 Jun 2018 Article published 10.1186/s12885-018-4605-1

You can find further information about peer review here.

Back to article page